References
- SinhaVRKumriaRPolysaccharides in colon-specific drug deliveryInt J Pharm20012241–2 19 3811472812
- PawarPKGautamCDesign, optimization and evaluation of mesalamine matrix tablet for colon drug delivery systemJ Pharm Invest2016461 67 78
- SteedKPHooperGMontiNBenedettiMSFornasiniGWildingIRThe use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (Time Clock system)J Control Release1997492–3 115 122
- MuraokaMHuZShimokawaTEvaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteersJ Control Release1998521–2 119 1299685942
- YouYCDongLYDongKIn vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapyCarbohydr Polym2015130 243 25326076623
- YangLWatanabeSLiJEffect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (Codes)Pharm Res2003203 429 43412669964
- McConnellELLiuFBasitAWColonic treatments and targets: issues and opportunitiesJ Drug Target2009175 335 36319555265
- LiuHYangXGNieSFChitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigationInt J Pharm20073321–2 115 12417052871
- MooreWEHoldemanLVDiscussion of current bacteriological investigations of the relationships between intestinal flora, diet, and colon cancerCancer Res19753511 Pt 2 3418 3420
- SimonGLGorbachSLIntestinal flora in health and diseaseGastroenterology1984861 174 1936357937
- TozakiHKomoikeJTadaCChitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colonJ Pharm Sci1997869 1016 10219294815
- TozakiHFujitaTOdoribaTColon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in ratsLife Sci19996413 1155 116210210278
- TozakiHOdoribaTOkadaNChitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in ratsJ Control Release2002821 51 6112106976
- ZambitoYDi ColoGPreparation and in vitro evaluation of chitosan matrices for colonic controlled drug deliveryJ Pharm Pharm Sci200362 274 28112935439
- ZhangHAlsarraIANeauSHAn in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colonInt J Pharm20022391–2 197 20512052705
- CerchiaraTAbruzzoAParolinCMicroparticles based on chitosan/carboxymethylcellulose polyelectrolyte complexes for colon delivery of vancomycinCarbohydr Polym2016143 124 13027083351
- ShimonoNTakatoriTUedaMMoriMHigashiYNakamuraYChitosan dispersed system for colon-specific drug deliveryInt J Pharm20022451–2 45 5412270241
- XiaWLiuPLiuJAdvance in chitosan hydrolysis by non-specific cellulasesBioresour Technol20089915 6751 676218328693
- KaurGRanaVJainSTiwaryAKColon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complexAAPS PharmSciTech2010111 36 4520017011
- BigucciFLuppiBCerchiaraTChitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycinEur J Pharm Sci2008355 435 44118951977
- KhanKAThe concept of dissolution efficiencyJ Pharm Pharmacol1975271 48 49235616
- SongWHYeomDWLeeDHIn situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery systemArch Pharm Res2014375 626 63523852645
- SongSHChaeBRSohnSIFormulation of controlled-release pelubiprofen tablet using Kollidon SRInt J Pharm20165112 864 87527492018
- MoustafineRIMargulisEBSibgatullinaLFKemenovaVAVan den MooterGComparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug deliveryEur J Pharm Biopharm2008701 215 22518691856
- DavisSSStockwellAFTaylorMJThe effect of density on the gastric emptying of single- and multiple-unit dosage formsPharm Res198634 208 21324271583
- LiJYangLFergusonSMIn vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and IIIAAPS PharmSciTech200234 59 67
- CummingsJHMacfarlaneGTThe control and consequences of bacterial fermentation in the human colonJ Appl Bacteriol1991706 443 4591938669
- OmwanchaWKoubaCYelamanchiliSNeauSHColon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tabletsDrug Dev Ind Pharm2011378 945 95321417614
- FukamizoTHondaYGotoSBoucherIBrzezinskiRReaction mechanism of chitosanase from Streptomyces sp. N174Biochem J19953112 377 3837487871
- SmoumRRubinsteinASrebnikMChitosan-pentaglycine-phenylboronic acid conjugate: a potential colon-specific platform for calcitoninBioconjug Chem2006174 1000 100716848408
- WatermanKCSuttonSCA computational model for particle size influence on drug absorption during controlled-release colonic deliveryJ Control Release2003862–3 293 30412526825
- IqbalZBabarAAshraMControlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion methodDrug Dev Ind Pharm2002282 129 13411926356
- DesaiJAlexanderKRigaACharacterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled releaseInt J Pharm20063081 115 12316326055
- YeomDWSongYSKimSRDevelopment and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture designInt J Nanomedicine201510 3865 387826089663
- ParhiRSureshPPatnaikSFormulation optimization of PVA/HPMC cryogel of Diltiazem HCl using 3-level factorial design and evaluation for ex vivo permeationJ Pharm Invest2015453 319 327
- ZuYZhangYZhaoXZhangQLiuYJiangROptimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM)Int J Nanomedicine20094 321 33320054435